Table 2. Association of hematoma morphology and intraventricular hemorrhage.
| Variable | Unadjusted | Model 1 | Model 2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |||
| Hematoma volume | 1.021 | 0.990–1.053 | 0.19 | 1.001 | 0.959–1.044 | 0.98 | 0.986 | 0.923–1.054 | 0.69 | ||
| SI (per 0.1) | 0.432 | 0.261–0.715 | 0.001 | 0.353 | 0.186–0.671 | 0.001 | 0.252 | 0.089–0.709 | 0.009 | ||
| A/B ratio† | 0.436 | 0.179–1.062 | 0.07 | 0.792 | 0.267–2.346 | 0.67 | 0.558 | 0.105–2.978 | 0.50 | ||
| LMA (per 10°) | 1.281 | 1.112–1.476 | 0.001 | 1.338 | 1.120–1.598 | 0.001 | 1.281 | 1.007–1.630 | 0.04 | ||
†, A: the largest area of hematoma; B: the largest diameter 90° to A on the same slice. Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, medical history (hypertension, diabetes mellitus, previous stroke, use of antiplatelet agents or anticoagulants within 72 h of onset), admission systolic blood pressure, admission diastolic blood pressure, admission glucose, time to initial CT, and thalamic involvement. OR, odds ratio; CI, confidence interval; SI, sphericity index; LMA, largest diameter-midline angle; CT, computed tomography.